Skip to search formSkip to main contentSkip to account menu

MS 153

Known as: MS-153 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Effects of (R)‐(−)‐5‐methyl‐1‐nicotinoyl‐2‐pyrazoline on glutamate transporter 1 and cysteine/glutamate exchanger as well as ethanol drinking behavior in male, alcohol‐preferring rats
Alcohol consumption is largely associated with alterations in the extracellular glutamate concentrations in several brain reward… 
Highly Cited
2014
Highly Cited
2014
Effects of MS-153 on chronic ethanol consumption and GLT1 modulation of glutamate levels in male alcohol-preferring rats
We have recently shown that upregulation of glutamate transporter 1 (GLT1) in the brain is associated in part with reduction in… 
Highly Cited
2005
Highly Cited
2005
Effect of MS-153, a glutamate transporter activator, on the conditioned rewarding effects of morphine, methamphetamine and cocaine in mice
2004
2004
Effect of MS-153 on the acquisition and expression of conditioned fear in rats.
2002
2002
Effect of MS-153 on the development of behavioral sensitization to locomotion- and ataxia-inducing effects of phencyclidine
Abstract. Rationale: Repeated administration of phencyclidine (PCP) produces behavioral sensitization to PCP. Although the… 
2002
2002
Effect of MS-153 on the development of behavioral sensitization to stereotypy-inducing effect of phencyclidine
Highly Cited
2001
Highly Cited
2001
Inhibition of morphine tolerance and dependence by MS-153, a glutamate transporter activator.
1999
1999
Ion Channel Modulation as the Basis for Neuroprotective Action of MS‐153
ABSTRACT: MS‐153, (R)‐(‐)‐5‐methyl‐1‐nicotinoyl‐2‐pyrazoline, is a new neuroprotective durg. Recent data in the literature… 
1997
1997
Cerebroprotective effects of a novel pyrazoline derivative, MS-153, on focal ischemia in rats.
MS-153 ((R)-(-)-5-methyl-1-nicotinoyl-2-pyrazoline) is a novel pyrazoline compound that has potent cerebroprotective effects in… 
1996
1996
Inhibitory effect of MS-153 on elevated brain glutamate level induced by rat middle cerebral artery occlusion.
BACKGROUND AND PURPOSE In this study we investigated the effects of a novel compound, MS-153 ([R]-[-]-5-methyl-1-nicotinoyl-2… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)